Literature DB >> 15703264

Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in mice following acute oral administration of arsenate.

E M Kenyon1, L M Del Razo, M F Hughes.   

Abstract

The relationship of exposure dose and tissue concentration of parent chemical and metabolites is a critical issue in cases where toxicity may be mediated by a metabolite or by parent chemical and metabolite acting together. This has emerged as an issue for inorganic arsenic (iAs), because both its trivalent and pentavalent methylated metabolites have unique toxicities; the methylated trivalent metabolites also exhibit greater potency than trivalent inorganic arsenic (arsenite, As(III)) for some endpoints. In this study, the time-course tissue distributions for iAs and its methylated metabolites were determined in blood, liver, lung, and kidney of female B6C3F1 mice given a single oral dose of 0, 10, or 100 micromol As/kg (sodium arsenate, As(V)). Compared to other organs, blood concentrations of iAs, mono- (MMA), and dimethylated arsenic (DMA) were uniformly lower across both dose levels and time points. Liver and kidney concentrations of iAs were similar at both dose levels and peaked at 1 h post dosing. Inorganic As was the predominant arsenical in liver and kidney up to 1 and 2 h post dosing, with 10 and 100 micromol As/kg, respectively. At later times, DMA was the predominant metabolite in liver and kidney. By 1 h post dosing, concentrations of MMA in kidney were 3- to 4-fold higher compared to other tissues. Peak concentrations of DMA in kidney were achieved at 2 h post dosing for both dose levels. Notably, DMA was the predominant metabolite in lung at all time points following dosing with 10 micromol As/kg. DMA concentration in lung equaled or exceeded that of other tissues from 4 h post dosing onward for both dose levels. These data demonstrate distinct organ-specific differences in the distribution and methylation of iAs and its methylated metabolites after exposure to As(V) that should be considered when investigating mechanisms of arsenic-induced toxicity and carcinogenicity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15703264     DOI: 10.1093/toxsci/kfi107

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  23 in total

1.  Arsenicals in maternal and fetal mouse tissues after gestational exposure to arsenite.

Authors:  Vicenta Devesa; Blakely M Adair; Jie Liu; Michael P Waalkes; Bhalchandra A Diwan; Miroslav Styblo; David J Thomas
Journal:  Toxicology       Date:  2006-05-03       Impact factor: 4.221

2.  Direct analysis and stability of methylated trivalent arsenic metabolites in cells and tissues.

Authors:  Jenna M Currier; Milan Svoboda; Tomáš Matoušek; Jiří Dědina; Miroslav Stýblo
Journal:  Metallomics       Date:  2011-10-21       Impact factor: 4.526

3.  Chronic arsenic exposure in nanomolar concentrations compromises wound response and intercellular signaling in airway epithelial cells.

Authors:  Cara L Sherwood; R Clark Lantz; Scott Boitano
Journal:  Toxicol Sci       Date:  2012-11-30       Impact factor: 4.849

4.  Direct analysis of methylated trivalent arsenicals in mouse liver by hydride generation-cryotrapping-atomic absorption spectrometry.

Authors:  Jenna M Currier; Milan Svoboda; Diogo P de Moraes; Tomás Matousek; Jirí Dĕdina; Miroslav Stýblo
Journal:  Chem Res Toxicol       Date:  2011-03-11       Impact factor: 3.739

5.  Arsenic alters ATP-dependent Ca²+ signaling in human airway epithelial cell wound response.

Authors:  Cara L Sherwood; R Clark Lantz; Jefferey L Burgess; Scott Boitano
Journal:  Toxicol Sci       Date:  2011-02-25       Impact factor: 4.849

6.  Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity.

Authors:  Xiao-Jun Wang; Zheng Sun; Weimin Chen; Kylee E Eblin; Jay A Gandolfi; Donna D Zhang
Journal:  Toxicol Appl Pharmacol       Date:  2007-08-07       Impact factor: 4.219

7.  Arsenic and lung disease mortality in Bangladeshi adults.

Authors:  Maria Argos; Faruque Parvez; Mahfuzar Rahman; Muhammad Rakibuz-Zaman; Alauddin Ahmed; Samar Kumar Hore; Tariqul Islam; Yu Chen; Brandon L Pierce; Vesna Slavkovich; Christopher Olopade; Muhammad Yunus; John A Baron; Joseph H Graziano; Habibul Ahsan
Journal:  Epidemiology       Date:  2014-07       Impact factor: 4.822

Review 8.  Aquaglyceroporins and metalloid transport: implications in human diseases.

Authors:  Hiranmoy Bhattacharjee; Barry P Rosen; Rita Mukhopadhyay
Journal:  Handb Exp Pharmacol       Date:  2009

9.  Nrf2 protects against As(III)-induced damage in mouse liver and bladder.

Authors:  Tao Jiang; Zheping Huang; Jefferson Y Chan; Donna D Zhang
Journal:  Toxicol Appl Pharmacol       Date:  2009-06-16       Impact factor: 4.219

10.  Arsenic upregulates MMP-9 and inhibits wound repair in human airway epithelial cells.

Authors:  Colin E Olsen; Andrew E Liguori; Yue Zong; R Clark Lantz; Jefferey L Burgess; Scott Boitano
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-06-06       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.